关键词：SNP；基因分型；筛选；遗传变异分析；基因组
摘 要：SNP genotyping is the screening and analysis of genetic variations of SNPs in the genome of various species. SNPs are commonly present in all species including humans. SNP genotyping and analysis technology can analyze thousands of SNPs and has the potential for wholegenome genotyping. It is the most common genetic variation that occurs in the genetic makeup. It is an emerging field in life science, which provides an in-depth analysis of SNPs. It is generally used by researchers for genomics study. It has a broad range of applications in several industries such as Pharmaceuticals and Pharmacogenomics, Diagnostics Research, Agriculture Biotechnology, and Breeding and Animal Livestock. There are several technologies which are used for SNP genotyping and analysis such as SNP GeneChips and microarrays, TaqMan allelic discrimination, SNP by pyrosequencing, SNPlex, and MassARRAY MALDI-TOF.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Technology

08. Market Segmentation by Application

09. Geographical Segmentation

09.1 SNP Genotyping and Analysis Market in the

Americas

09.1.1 Market Size and Forecast

09.2 SNP Genotyping and Analysis Market in the

EMEA Region

09.2.1 Market Size and Forecast

09.3 SNP Genotyping and Analysis Market in the

APAC Region

09.3.1 Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Acquisitions and Agreements

17.2 Vendor Analysis

17.3 Other Prominent Vendors

18. Key Vendor Analysis

18.1 Affymetrix

18.1.1 Key Facts

18.1.2 Business Overview

18.1.3 Business Segmentation

18.1.4 Business Segmentation by Revenue 2013

18.1.5 Business Segmentation by Revenue 2012 and 2013

18.1.6 Sales by Geography

18.1.7 Business Strategy

18.1.8 Key Information

18.1.9 SWOT Analysis

18.1.10 Strengths

18.1.11 Weaknesses

18.1.12 Opportunities

18.1.13 Threats

18.2 F. Hoffmann-La Roche

18.2.1 Key Facts

18.2.2 Business Overview

18.2.3 Business Segmentation

18.2.4 Business Segmentation by Revenue 2012 and 2013

18.2.5 Sales by Geography

18.2.6 Business Strategy

18.2.7 Key Information

18.2.8 SWOT Analysis

18.2.9 Strengths

18.2.10 Weaknesses

18.2.11 Opportunities

18.2.12 Threats

18.3 Illumina

18.3.1 Key Facts

18.3.2 Business Overview

18.3.3 Business Segmentation

18.3.4 Sales by Geography

18.3.5 Business Strategy

18.3.6 Key Information

18.3.7 SWOT Analysis

18.3.8 Strengths

18.3.9 Weaknesses

18.3.10 Opportunities

18.3.11 Threats

18.4 Thermo Fisher Scientific

18.4.1 Key Facts

18.4.2 Business Overview

18.4.3 Business Segmentation by Revenue

18.4.4 Product Segmentation by Revenue

18.4.5 Sales by Geography

18.4.6 Business Strategy

18.4.7 Key Information

18.4.8 SWOT Analysis

18.4.9 Strengths

18.4.10 Weaknesses

18.4.11 Opportunities

18.4.12 Threats

19. Other Reports in this Series